Investors

 

Investors

Our principal investor is Connecticut Innovations, which has a long history of investing in the life sciences. Since 1995, Connecticut Innovations has invested over $100 million in 50+ bioscience companies. Our second leading investor is Stonehenge Growth Capital, which manages funds totaling $370 million, with 37 active portfolio companies. In addition, we have received significant non-dilutive grant funding from the National Institutes of Health, Crohn's & Colitis Foundation, and Kenneth Rainin Foundation.